Space-based research often generates dual-use technologies with terrestrial applications. Illustrate this with examples from India's space medicine initiatives and their potential healthcare impact.

Space medicine studies how microgravity, radiation, isolation and confinement affect the human body. Because it must keep humans alive with minimal equipment far from a hospital, its solutions travel back to Earth — a dual-use pattern now visible in India's Gaganyaan-driven initiatives.

India's space medicine initiatives

• ISRO–AIIMS New Delhi Framework MoU (March 2026) for joint research on human physiology, behavioural health, immunology and microbiome, neuroscience, nutrition and musculoskeletal change in microgravity, through ground-based and space-based studies [1].
• ISRO–SCTIMST MoU covering biomedical support systems, radiation biology, telemedicine protocols and the crew medical kit — pairing device engineering with AIIMS's clinical strength [2].
• Both are anchored in Gaganyaan, in its final phase with crewed flight targeted for Q1 2027, and in longer missions to the Bharatiya Antariksh Station (2035) and a crewed lunar landing (2040) [3].

Dual-use pathways to terrestrial healthcare

• Telemedicine and communication protocols designed for crew–ground medical consultation are directly transferable to tele-consultation in remote, hilly and tribal districts [2].
• Crew medical kits and portable diagnostics, built for extreme volume and power constraints, suit ambulances, disaster relief and primary health centres [2].
• Musculoskeletal and bone-density countermeasures for microgravity map onto osteoporosis, sarcopenia and rehabilitation medicine for an ageing population [1].
• Radiation biology research informs radiotherapy safety and occupational radiation protection [2].
• Behavioural health and confinement studies carry lessons for ICU and quarantine mental-health care [1].

Enabling conditions Impact depends on translation: sustained funding, ethics review for human subjects, and industry linkages to convert prototypes into affordable products.

Thus space medicine is not a luxury of the space programme but an investment with a double dividend — mission assurance for Gaganyaan and frugal, deployable technologies for India's health system. Institutionalising ISRO's partnerships with premier medical institutions, and channelling spin-offs into the National Digital Health ecosystem, can make human spaceflight a driver of equitable healthcare, advancing India's strategic autonomy and SDG-3 together.